11. P-294Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress. (20th June 2018) Authors: Kato, T; Satake, H; Oba, K; Kagawa, Y; Yasui, H; Nakamura, M; Watanabe, T; Matsumoto, T; Hirata, K; Muro, K; Komatsu, Y; Yoshino, T; Yamazaki, K; Mishima, H; Kotaka, M; Tsuji, A; Kakeji, Y; Oki, E; Nagata, N; Sakamoto, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. P1169Severity of chronic kidney disease predicts the prevalence of left atrial low-voltage areas. (19th March 2018) Authors: Matsuda, Y; Masuda, M; Asai, M; Iida, O; Okamoto, S; Ishihara, T; Nanto, K; Kanda, T; Tsujimura, T; Okuno, S; Ohashi, T; Kawai, H; Tsuji, A; Hata, Y; Mano, T Journal: Europace Issue: Volume 20(2018)Supplement 1 Page Start: i224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. PD-013RAS mutations in circulating tumor DNA (ctDNA) and clinical outcomes of rechallenge treatments with anti-EGFR antibodies in patients with metastatic colorectal cancer (mCRC). (2nd July 2019) Authors: Sunakawa, Y; Nakamura, M; Ishizaki, M; Kataoka, M; Satake, H; Kitazono, M; Yanagisawa, H; Kawamoto, Y; Kuramochi, H; Ohori, H; Nakamura, M; Takahashi, K; Maeda, F; Komeno, C; Takeuchi, M; Fujii, M; Yoshino, T; Ichikawa, W; Tsuji, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗